CLINICAL_TRIALS
trial_result
· 2017-08-10
Clinical Trial Update: The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial [Phase 3]
Summary
Phase 3 trial evaluating darapladib for stabilizing atherosclerotic plaque completed; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Atherosclerosis | Phase 3 | Status: COMPLETED | Results posted: 2017-08-10